Bleomycin Lung Injury: A Case Report and Review of the Literature-Juniper Publishers
Juniper Publishers - Journal of Anesthesia Abstract Bleomycin is a drug used to in the treatment of Hodgkin's Lymphoma, amongst other tumours. Bleomycin has been implicated in causing pneumonitis and pulmonary fibrosis, now termed Bleomycin Lung Injury (BLI). BLI is a much debated subject, in terms of both its pathogenesis and management of patients after diagnosis. In this paper, we reviewed the current knowledge of Bleomycin-Induced Lung Injury from a case report perspective. We will describe the case of a patient with BLI presenting to our ICU and discuss the available literature. Keywords: Bleomycin; Acute Lung Injury, Chronic Lung Injury, Pneumonitis, Drug Toxicities, Free radicals Abbreviations: BLI: Bleomycin Lung Injury; ARDS: Acute Respiratory Distress Syndrome; ICU: intensive care unit Introduction Bleomycin is a glycopeptide antibiotic, originally isolated from Streptomyces verticillus, and discovered t...